Cost-Effectiveness of a Combination of Renin-Angiotensin System Inhibitors (Ras)/Calcium Channel Blockers (Ccb) or Ras Monotherapy to Retard Progression of Kidney Disease in Malaysia
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.08.501
https://www.valueinhealthjournal.com/article/S1098-3015(16)31081-6/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2504
First Page :
A847
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31081-6&doi=10.1016/j.jval.2016.08.501